CD79A and viral infectious disease: KEGG pathways enriched in the hyper-mCpH enhancers included immune-related diseases and pathways, such as inflammatory bowel disease (hsa05321), intestinal immune network for IgA production (hsa04672), and virus infections (hsa05164 and hsa05168) (Fig. 4b).